Parkwood LLC Dice Therapeutics, Inc. Transaction History

Parkwood LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$25.86 - $46.71 $11,197 - $20,225	433 Added 2.46%	18,052 $839,000
Q1 2023 May 15, 2023	BUY	$26.05 - $32.31 $458,974 - $569,269	17,619 New	17,619 $505,000
Q2 2022 Aug 15, 2022	SELL	$13.19 - $22.1 $163,780 - $274,415	-12,417 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$14.54 - $25.02 $180,543 - $310,673	12,417 New	12,417 $238,000

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Parkwood LLC, based on Form 13F filings with the SEC.

Stay updated on Parkwood LLC with notifications on news.